基本信息
views: 40
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research Abstract
1. Develop more effective therapies for hepatocellular carcinoma and cholangiocarcinoma through phase I, II and III clinical trials.
2. Identify novel circulating and imaging biomarkers for targeted therapeutics that have prognostic and/or predictive significance.
3. Define and characterize known or novel genetic mutations in hepatocellular carcinoma and cholangiocarcinoma, and assess their potential correlation with clinical outcomes and as therapeutic targets.
4. Dissect the molecular mechanism of drug resistance to targeted therapy in hepatobiliary cancers.
1. Develop more effective therapies for hepatocellular carcinoma and cholangiocarcinoma through phase I, II and III clinical trials.
2. Identify novel circulating and imaging biomarkers for targeted therapeutics that have prognostic and/or predictive significance.
3. Define and characterize known or novel genetic mutations in hepatocellular carcinoma and cholangiocarcinoma, and assess their potential correlation with clinical outcomes and as therapeutic targets.
4. Dissect the molecular mechanism of drug resistance to targeted therapy in hepatobiliary cancers.
Research Interests
Papers共 482 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
LANCET GASTROENTEROLOGY & HEPATOLOGYno. 4 (2024): 310-322
Gastroenterologyno. 5 (2024)
Xupeng Yang, Chen Yang,Shu Zhang,Andrew X. Zhu,Haigang Geng,Rene Bernards,Wenxin Qin,Jia Fan,Cun Wang,Qiang Gao
The lancet. Gastroenterology & hepatologyno. 4 (2024): 310-322
Bin Fan,Ghassan K Abou-Alfa,Andrew X Zhu,Shuchi S Pandya, Hongxia Jia,Feng Yin,Camelia Gliser, Zhaowei Hua,Mohammad Hossain,Hua Yang
ONCOLOGIST (2023)
JAMA oncologyno. 12 (2023): 1651-1659
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn